GHK-Cu Dosing Guide: Topical, Subcutaneous, and Microneedling Protocols

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. What makes GHK-Cu unique among peptides used in research protocols is its versatility: it can be administered through three distinct routes — topical application, subcutaneous injection, and microneedling — each with different bioavailability profiles, target outcomes, and dosing considerations.

This guide breaks down the dosing protocols for all three methods, covers reconstitution and concentration math for injectable GHK-Cu, explains how to prepare microneedling serum, and addresses the practical differences between routes so researchers can choose the approach that best fits their protocol goals.

Understanding GHK-Cu: Why Multiple Routes Matter

GHK-Cu was first identified in the 1970s, and research over the following decades has suggested it plays roles in wound repair, collagen synthesis, anti-inflammatory signaling, and antioxidant enzyme regulation. The copper ion bound to the GHK tripeptide appears to be essential for many of these effects — the peptide acts as a delivery vehicle for copper to tissues that need it.

The reason GHK-Cu is used through multiple administration routes comes down to targeting. Studies indicate that topical application delivers the peptide primarily to the dermal and epidermal layers, making it relevant for skin-focused research. Subcutaneous injection provides systemic delivery, reaching tissues beyond the skin. Microneedling falls somewhere in between — it creates micro-channels that allow the peptide to penetrate deeper into the dermis than topical application alone, while still concentrating the compound locally.

Route 1: Topical GHK-Cu Application

Topical GHK-Cu is the most accessible administration method and the most extensively studied route for skin-related research. It requires no injection equipment and is applied like any other serum or cream.

Topical Dosing Parameters

Parameter	Standard Range	Notes
Concentration	1-2%	Most commercial serums use 1%; 2% for targeted protocols
Application Frequency	1-2 times daily	Once daily is standard; twice daily for intensive protocols
Amount per Application	3-5 drops or pea-sized	Thin layer over target area
Protocol Duration	8-12 weeks minimum	Collagen remodeling is slow; 12 weeks for meaningful assessment

Application Guidelines

Apply to clean, dry skin — after cleansing but before heavier moisturizers or oils
Allow the serum to absorb for 2-3 minutes before applying other products
GHK-Cu has a characteristic blue tint from the copper ion; this is normal and expected
Avoid combining with strong acids (AHAs, BHAs, vitamin C at low pH) in the same application, as acidic pH can destabilize the copper complex
Store topical GHK-Cu serums in a cool, dark place; refrigeration extends shelf life

Topical GHK-Cu requires no reconstitution and no injections, making it the lowest-barrier entry point for researchers exploring this peptide.

Route 2: Subcutaneous GHK-Cu Injection

Injectable GHK-Cu provides systemic delivery and is used in protocols targeting outcomes beyond the skin — including tissue repair, systemic anti-inflammatory effects, and overall recovery support. This route requires reconstitution from lyophilized powder and standard subcutaneous injection technique.

Injectable Dosing Parameters

Parameter	Standard Range	Notes
Daily Dose	200-500 mcg	Most protocols use 200-300 mcg; 500 mcg is the upper range
Injection Frequency	Once daily	Some protocols use 5 days on, 2 days off
Injection Route	Subcutaneous	Abdomen or thigh; rotate sites
Cycle Length	4-8 weeks	Followed by 2-4 weeks off
Common Vial Sizes	5 mg, 10 mg, 50 mg	Varies by supplier

Reconstitution and Dose Calculation

GHK-Cu is typically supplied as a lyophilized (freeze-dried) powder in sealed vials. Reconstitution with bacteriostatic water is required before injection.

Here are common reconstitution scenarios with the resulting injection volumes for different doses:

Vial Size	BAC Water	Concentration	200 mcg Dose	300 mcg Dose	500 mcg Dose
5 mg	2 mL	2,500 mcg/mL	0.08 mL (8 units)	0.12 mL (12 units)	0.20 mL (20 units)
5 mg	5 mL	1,000 mcg/mL	0.20 mL (20 units)	0.30 mL (30 units)	0.50 mL (50 units)
10 mg	2 mL	5,000 mcg/mL	0.04 mL (4 units)	0.06 mL (6 units)	0.10 mL (10 units)
50 mg	5 mL	10,000 mcg/mL	0.02 mL (2 units)	0.03 mL (3 units)	0.05 mL (5 units)

Notice that with larger vial sizes and less water, the injection volumes become very small — sometimes just 2-5 units on an insulin syringe. For GHK-Cu, using a 0.3 mL (30-unit) syringe with half-unit markings is strongly recommended for accurate measurement. Alternatively, adding more BAC water creates a less concentrated solution with larger, easier-to-measure injection volumes.

Use our reconstitution calculator to quickly determine the exact injection volume for your specific vial size and water volume. For detailed guidance on reconstitution technique, including how to properly add water to a lyophilized vial without damaging the peptide, see our peptide reconstitution guide.

Choosing the Right Syringe

Because GHK-Cu doses are relatively small in volume, syringe selection matters more than with higher-volume injections. Our needle gauge guide for peptide injections covers syringe sizing, needle gauge options, and how to match your equipment to your injection volume.

Track your protocol with our free Daily Peptide Tracker

Route 3: GHK-Cu with Microneedling

Microneedling combined with GHK-Cu represents a middle ground between topical and injectable administration. The microneedling device creates thousands of controlled micro-injuries in the skin, which temporarily opens channels that allow the peptide to penetrate far deeper than passive topical application. This concentrates the GHK-Cu locally in the dermis while achieving deeper penetration than a simple serum application.

Microneedling Protocol Parameters

Parameter	Standard Range	Notes
GHK-Cu Amount	0.5-1 mg per session	Dissolved in serum or saline carrier
Carrier Volume	1-2 mL	Sterile saline or hyaluronic acid base
Needle Depth	0.5-1.5 mm	0.5mm for superficial; 1.0-1.5mm for deeper protocols
Session Frequency	Every 2-4 weeks	Skin needs time to heal between sessions
Protocol Length	4-6 sessions	Then reassess; maintenance sessions every 4-8 weeks

Preparing the Microneedling Serum

To prepare a GHK-Cu microneedling solution from lyophilized powder:

Reconstitute the vial: Add sterile water or bacteriostatic water to the GHK-Cu vial. For a 5mg vial, adding 5 mL of water creates a 1 mg/mL concentration
Calculate the volume needed: For a 1mg dose at 1 mg/mL concentration, draw 1 mL. For 0.5mg, draw 0.5 mL
Mix with carrier (optional): The reconstituted solution can be applied directly, or mixed with a hyaluronic acid serum as a carrier to improve glide during the microneedling session
Apply before and during needling: Apply approximately half the solution to the clean treatment area before microneedling, and the remaining half during or immediately after the needling pass

Needle Depth by Area

Treatment Area	Recommended Depth	Rationale
Forehead	0.5-0.75 mm	Thinner skin; bone close to surface
Cheeks	1.0-1.5 mm	Thicker dermis; can tolerate deeper needling
Jawline and Chin	0.75-1.0 mm	Moderate thickness
Under Eyes	0.25-0.5 mm	Very thin, delicate skin — use caution
Neck	0.5-0.75 mm	Thinner skin; prone to irritation
Scalp	0.5-1.0 mm	Used in hair-related research protocols

Comparing the Three Routes: Bioavailability and Use Cases

Each administration route delivers GHK-Cu to different tissue depths with different efficiency. Here is a side-by-side comparison to help determine which route aligns with specific protocol goals:

Factor	Topical	Subcutaneous Injection	Microneedling
Primary Target	Epidermis and upper dermis	Systemic (whole body)	Deep dermis, locally concentrated
Bioavailability	Low (skin barrier limits absorption)	High (direct to bloodstream)	Moderate (enhanced by micro-channels)
Reconstitution Needed	No (pre-made serums available)	Yes	Yes (if using lyophilized powder)
Frequency	Daily	Daily	Every 2-4 weeks
Typical Dose per Application	Not precisely measured (serum %)	200-500 mcg	500-1,000 mcg per session
Equipment Required	None	Syringe, needles, BAC water	Derma pen/roller, syringe for prep
Downtime	None	None	12-48 hours of redness

Some protocols combine routes — for example, using daily topical GHK-Cu serum between monthly microneedling sessions, or pairing daily subcutaneous injections with topical application over a specific area. Research suggests that multi-route approaches may be synergistic, though this has not been extensively studied in controlled trials.

Storage Considerations for Copper Peptides

GHK-Cu has some specific storage requirements that differ from many other peptides, primarily because of the copper ion:

Lyophilized (unreconstituted): Store at room temperature or refrigerated. Stable for months to years when kept dry and sealed. Avoid exposure to light
Reconstituted solution: Refrigerate at 36-46°F (2-8°C). Use within 2-4 weeks. Bacteriostatic water extends usable life compared to sterile water
Topical serums: Store in dark glass bottles away from direct sunlight. Refrigeration extends potency. Discard if the blue color fades significantly or the solution becomes cloudy
Copper sensitivity: Do not store reconstituted GHK-Cu in metal containers or allow prolonged contact with metals. Use glass vials or plastic syringes

The blue-green color of GHK-Cu solutions is caused by the copper ion and is a sign of an intact compound. Loss of color may indicate degradation.

Frequently Asked Questions

Can I use the same reconstituted GHK-Cu vial for both injection and microneedling?

Technically yes, provided the vial was reconstituted with bacteriostatic water and handled with sterile technique. However, many protocols recommend keeping separate vials for each purpose. Microneedling involves applying the solution to an open skin surface, and cross-contamination between the vial and the skin could introduce bacteria into the vial used for injection. If using the same vial, always draw your injection dose first with a clean syringe before drawing the microneedling portion.

Is topical GHK-Cu effective enough on its own, or is injection necessary for meaningful results?

Research suggests that topical GHK-Cu at 1-2% concentration can produce measurable effects on skin parameters — studies have documented improvements in collagen density, skin thickness, and elasticity with consistent topical use over 12 weeks. However, the skin barrier limits how much peptide actually reaches the target tissues. For systemic outcomes beyond the skin, subcutaneous injection is the standard approach. The right route depends entirely on the protocol's goals.

How does microneedling depth affect GHK-Cu absorption?

Deeper needle settings create larger, more open channels that allow greater peptide penetration. A 0.5mm depth primarily affects the epidermis, while 1.0-1.5mm reaches into the dermis where collagen and elastin fibers reside. However, deeper needling also causes more inflammation, bleeding, and longer recovery time. Most protocols start at 0.5mm and increase depth gradually based on tolerance and the specific treatment area.

Are there any compounds that should not be combined with GHK-Cu?

GHK-Cu should not be applied topically at the same time as strong acids (such as glycolic acid, salicylic acid, or low-pH vitamin C serums), as acidic conditions can disrupt the copper-peptide bond. If using these products in the same routine, apply them at different times of day. For injectable protocols, GHK-Cu is sometimes combined with other peptides like BPC-157 or TB-500, though such combinations should be researched individually as stability data for mixed solutions is limited.

Disclaimer: This article is for educational and informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting any new protocol. All compounds discussed are referenced in the context of research use only.